Clinuvel Pharmaceuticals Limited

ASX (AUD): Clinuvel Pharmaceuticals Limited (CUV)

Last Price

14.09

Today's Change

+0.10 (0.71%)

Day's Change

13.93 - 14.30

Trading Volume

47,955

Overview

Market Cap

705 Million

Shares Outstanding

50 Million

Avg Volume

90,038

Avg Price (50 Days)

14.43

Avg Price (200 Days)

14.96

PE Ratio

20.13

EPS

0.70

Earnings Announcement

20-Feb-2025

Previous Close

13.99

Open

14.00

Day's Range

13.93 - 14.3

Year Range

12.96 - 18.2

Trading Volume

47,955

Price Change Highlight

1 Day Change

0.71%

5 Day Change

0.28%

1 Month Change

-4.93%

3 Month Change

-18.93%

6 Month Change

-11.55%

Ytd Change

-13.35%

1 Year Change

-4.54%

3 Year Change

-65.51%

5 Year Change

-48.01%

10 Year Change

325.68%

Max Change

360.46%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 2 of 2 comments

Heavenly PUNTER Lynas Boleh

Potential 20 baggers

2019-06-11 14:49

venom

wah sifu, you really know how to lepak around hor, kikikikikiki

2019-06-11 23:58

Post a Comment